COMMUNIQUÉS West-GlobeNewswire

Biodesix Test Predicts Response to Atezolizumab in Lung Cancer
12/11/2018
Researchers Present New Data from Blood-Based Proteomic Test in Biomarkers and Immune Monitoring at SITC 2018 BOULDER, Colo. and WASHINGTON, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Researchers with Biodesix ® and Genentech, a [...]
Corvus Pharmaceuticals to Present at the 27th Annual Credit Suisse Healthcare Conference
12/11/2018
BURLINGAME, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted [...]
Vaccinex, Inc. Presents Overview of the Clinical Development of VX15 (pepinemab) for the Potential Treatment of Huntington’s Disease at the Huntington Study Group’s 2018 Annual Meeting
12/11/2018
Presentation and Poster Include Previously Announced Results of Cohort A of SIGNAL Trial ROCHESTER, N.Y., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company engaged [...]
CLS Holdings USA Announces City Trees Booth at MJBizCon
12/11/2018
Meet the City Trees Team at Booth #3913 City Trees Products Available in 35 Nevada Dispensaries City Trees Considers Expansion Beyond Nevada LAS VEGAS, Nov. 12, 2018 (GLOBE NEWSWIRE) -- CLS Holdings USA, Inc. (OTCQB: [...]
Gabriella's Kitchen Is Redefining The Cannabis Health and Wellness Industry -- CFN Media
12/11/2018
SEATTLE, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Cellectar Announces FDA Grants Exemption to Import Alert for CLR 131 Hematology Studies
12/11/2018
Clinical Trials to Advance Across Multiple Hematology Programs FLORHAM PARK, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB), a clinical-stage biopharmaceutical company focused on the [...]
Teligent, Inc. to Hold Conference Call for Third Quarter 2018 Results
12/11/2018
BUENA, N.J., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ:TLGT), a New Jersey-based specialty generic pharmaceutical company, announced the Company will hold a conference call at 4:30pm ET on Tuesday [...]
Anchiano Therapeutics Appoints Dr. Stephen Hoffman and Robert Connelly to Its Board of Directors
12/11/2018
Dr. Hoffman joins the Board as Chairman Mr. Connelly is appointed as a Director CAMBRIDGE, Mass., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. ( TASE: ANCN ), a clinical-stage biopharmaceutical company [...]
GENETIC-AF Phase 2B Clinical Trial Atrial Fibrillation Burden (AFB) Results Presented at American Heart Association 2018 Scientific Sessions
12/11/2018
AF detection by implanted Medtronic devices Similar trends for benefit in favor of Gencaro compared to active comparator for AF risk reduction observed by continuous monitoring with implanted devices compared to [...]
VistaGen Therapeutics Receives Notices of Allowance in Australia and Japan for AV-101 Patents Covering Treatment of Depression
12/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- VistaGen Therapeutics (NASDAQ: VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) [...]
Notice of Annual General Meeting
12/11/2018
Please see enclosed pdf. Attachment Notice
Sanyal Biotechnology and Innovate Biopharmaceuticals Present Data at AASLD Validating a Proprietary “Leaky Gut” Assay Demonstrating Reduced Intestinal Permeability with Larazotide Acetate Treatment in a NASH Preclinical Study
12/11/2018
Significant effect on gut epithelial integrity, a mechanism thought to be key for bacterial translocation leading to NAFLD and NASH. Innovate plans to launch a clinical development program for NASH in 2019 Data [...]
Organovo Partners With IIAM on Multi-Year Clinical Biomaterial Sourcing Agreement
12/11/2018
SAN DIEGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]
Novan Announces Corporate Update Conference Call and Webcast
12/11/2018
MORRISVILLE, N.C., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (NASDAQ:NOVN) today announced that the Company will host a conference call on Wednesday, November 14, at 8:30 a.m. Eastern Time [...]
Hospital for Special Care expands and extends relationship with Allscripts; Allscripts Sunrise helps Autism Center and COPD Disease Management programs earn first in nation Patient Centered Specialty Practice recognition for program types
12/11/2018
Not-for-profit hospital extends and further expands portfolio to include integrated registration, scheduling tools and medication management solutions CHICAGO, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX [...]
Matrix Medical Network Recognizes National Nurse Practitioner Week
12/11/2018
SCOTTSDALE, Ariz., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Matrix Medical Network (Matrix) is recognizing nurse practitioners nationwide and within our own clinical teams during National Nurse Practitioner Week, November 11- [...]
HTG Molecular Presenting at Upcoming Healthcare Conferences
12/11/2018
TUCSON, Ariz., Nov. 12, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a provider of instruments, reagents, and services for molecular profiling applications, today announced that TJ [...]
Cocrystal Pharma Reports 2018 Third Quarter Financial Results and Provides Corporate Update
12/11/2018
BOTHELL, WA, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that [...]
Immutep Presents Positive New Data from Ongoing TACTI-mel Study at Society for Immunotherapy of Cancer (SITC) 2018 Annual Meeting
12/11/2018
SYDNEY, Australia, Nov. 12, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep“ or “the Company“), a biotechnology company developing novel immunotherapy treatments for cancer and autoimmune [...]

Pages